Ratio of cathepsin B to stefin A identifies heterogeneity within Gleason histologic scores for human prostate cancer

Prostate

Volumn 48, Issue 4, 2001, Pages 274-284

  Sinha, Akhouri A ^a,c,e   Quast, Barry J ^a   Wilson, Michael J ^a,b,c   Fernandes, Eduardo T ^a   Reddy, Pratap K ^c   Ewing, Stephen L ^a,c   Sloane, Bonnie F ^d   Gleason, Donald F ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c Affairs Medical Center   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cathepsin B; Confocal microscopy; Endogenous inhibitor; Gleason histologic scores; Heterogeneity within individual Gleason score; Image analysis; Prostate cancer; Quantitative immunofluorescence; Ratios of CB to stefin A; Stefin A or cystatin A

Indexed keywords

CATHEPSIN B; PROSTATE SPECIFIC ANTIGEN; SCLEROPROTEIN; STEFIN A;

ARTICLE; CELL HETEROGENEITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORRELATION FUNCTION; FROZEN SECTION; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; SCORING SYSTEM; STATISTICAL ANALYSIS; TUMOR GROWTH;

AGED; AGED, 80 AND OVER; CATHEPSIN B; CYSTATINS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MICROSCOPY, PHASE-CONTRAST; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS;

EID: 0035450446     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.1107     Document Type: Article

References (33)

1. Use of nuclear morphometry, Gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer
2. Ability to predict biochemical progression using Gleason score and a computer-generated quantitative nuclear grade derived from cancer cell nuclei
3. Correlation of pathologic findings with progression after radical retropubic prostatectomy
4. Morphology of prostate cancer: The effects of multifocality on histological grade, tumor volume, and capsule penetration
5. Natural history of progression after PSA elevation following radical prostatectomy
6. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer
7. Is altered localization of cathepsin B casually related to malignant progression?
8. Cell producing cathepsin D, B, and L in human breast carcinoma and their association with prognosis
9. Cathepsin B and human tumor progression
10. Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteanase-2 (TIMP-2) in human benign and malignant prostatic tissue
11. Matrix metalloproteinases: Biologic activity and clinical implications
12. ECM and cell surface proteolysis: Regulating cellular ecology
13. Cathepsin B and its endogenous inhibitors: Role in tumor malignancy
14. Immunocytochemical and immunoelectron microscopic demonstration of cathepsin B in human malignant melanoma
15. Immunochemical analysis of cathepsin B in lung tumours: An independent prognostic factor for squamous cell carcinoma patients
16. Molecular regulation, membrane association, and secretion of tumor cathepsin B
17. Emerging roles for cysteine proteases in human biology
18. Immunohistochemical localization of cathepsin B in neoplastic human prostate
19. Tumor cell membrane cathepsin B
20. Cathepsin B expression in human tumors
21. An intracellular form of cathepsin B contributes to invasiveness in cancer
22. Localization of cathepsin B in normal and hyperplastic human prostate by immunoperoxidase and protein A gold techniques
23. Localization of a biotinylated cathepsin B oligonucleotide probe in human prostate including invasive cells and invasive edges by in situ hybridization
24. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score
25. Improved section adhesion for immunocytochemistry using high molecular weight polymers of L-lysine as a slide coating
26. Co-distribution of pro- and mature- cathepsin B forms in human prostate tumors detected by confocal and immunofluorescence microscopy
27. Classification of prostatic carcinomas
28. Histologic grading and clinical staging of prostatic carcinoma
29. Enzymatic acitivity of prostate-specific antigen and its reaction with extracellular serine proteinase inhibitors
30. Grading prostate cancer
31. Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications
32. Future prospects in prostate cancer
33. The challange of locally advanced prostate cancer